BASi (Bioanalytical Systems, Inc.) West Lafayette, IN www.basinc.com
Main Service Areas: Bioanalytical, Clinical, Preclinical
SERVICES & CAPABILITIES: BASi is a drug development services firm that offers a variety of services along the entire drug development continuum, including drug discovery, bioanalytical, toxicology, pharmaceutical analysis, and stability services.
THERAPEUTIC AREAS: analgesic, antidiabetic, antibiotic, antiviral, biomarker, cardiac, gastric, neurology/CNS, oncology, steroid, pain KEY INDUSTRY PARTNERS: xxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxx
KEY INDUSTRY PARTNERS: XenoGesis Limited, a BioCity Nottingham company; Pinnacle Technology of Lawrence, Kansas; Data Sciences International (DSI), the global leader in implantable telemetric physiological monitors, serving contract research organizations, pharmaceutical manufacturers and academic research institutions.
"I am very pleased that BASi has been recognized with a CRO Leadership Award for our excellent regulatory compliance and quality assurance. This is a tribute to all our staff at BASi. Our experienced scientific team strives to give clients confidence in meeting key milestones and having a successful review and audit of data. We know regulatory excellence is important to a successful partnership." —Anthony S. Chilton, Ph.D., president and chief executive officer
Bertin Pharma
Montignyle Bretonneux France www.bertinpharma.com (33) 139-306-220
Main Service Areas: Bioanalytical, Clinical, Preclinical
SERVICES & CAPABILITIES: Pharmaceutical development and clinical supplies, in vitro and in vivo microbiological safety assessments, preclinical and clinical studies, ADMET, biotransformation, biomarkers assay and bioanalysis, protein and host cell protein analysis, immunomonitoring, immunogenicity, formulation
THERAPEUTIC AREAS: All therapeutic areas
Key locations: Orleans, France; Artigues, France Contact: Xavier Morge info@bertinpharma.com
Key locations: West Lafayette, IN; Mount Vernon, IN Contact: Albert Hidalgo ahidalgo@basinc.com
"We are very pleased and proud that Bertin Pharma is recognized as one of the leading companies for productivity and regulato- ry categories. It is valuable information coming directly from our customers. I share this recognition with my teams, highly qualified and involved in the rendering of quality work and accuracy. On behalf of Bertin Pharma, thank you for this distinction that makes us a little more visible each day." — Xavier Morge, Bertin Pharma
bioRASI Aventura, FL www.biorasi.com (786) 388-0700
Main Service Areas: Clinical
SERVICES & CAPABILITIES: bioRASI, a full-service global CRO, optimizes clinical programs around quality, time, industry acceptance, cost, and service level. bioRASI offers optimized solutions through its focused divisions: drugs, biotherapeutics, and medical devices.
THERAPEUTIC AREAS: Dermatology, ophthalmology, endocrinology/women's health, cardiovascular, central nervous system, infectious diseases, oncology, gastroenterology, pulmonary, and others KEY INDUSTRY PARTNERS: Russian Academy of Sciences, Research Corporation Technologies (RCT), and Hospital Corporation of America
"bioRASI is pleased that our sponsors recognized us in the category of quality. Quality is one of the main criteria of our optimization-focused bioRASI Process Infrastructure (BPI). Striving to improve quality at bioRASI goes far beyond conventional approaches of adhering to regulatory requirements. We are focused on increasing the probability of trial success through strategies such as reducing trial-induced variability. Among other methods, this is accomplished through bioRASI's proprietary interactive training of investigators and patients." — Boris Reznik, Ph.D., chairman
The CRO Leadership Awards 2012 19
Key locations: California, Serbia, Florida, India, Russia, Ukraine Contact: Luke Passler lpassler@biorasi.com